ctrl K

Price Alert

Theseus Pharmaceuticals I... (THRX)

NASDAQ: THRX · Real-Time Price · USD

4.07

0.01 (0.25%)

At close: Feb 13, 2024, 9:59 PM

Theseus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	94.61M	244.66M
Short-Term Investments	103.37M	n/a
Long-Term Investments	13.82M	379K
Other Long-Term Assets	5.9M	2.57M
Receivables	n/a	n/a
Inventory	n/a	n/a
Other Current Assets	4.14M	3.31M
Total Current Assets	197.98M	247.97M
Property-Plant & Equipment	4.75M	11K
Goodwill & Intangibles	n/a	n/a
Total Long-Term Assets	24.47M	2.96M
Total Assets	222.45M	250.93M
Account Payables	4.97M	1M
Deferred Revenue	n/a	n/a
Short-Term Debt	743K	n/a
Other Current Liabilities	5.41M	2.68M
Total Current Liabilities	11.13M	3.68M
Long-Term Debt	3.24M	n/a
Other Long-Term Liabilities	466K	815K
Total Long-Term Liabilities	3.7M	815K
Total Liabilities	14.83M	4.5M
Total Debt	3.98M	n/a
Common Stock	4K	4K
Retained Earnings	-112.19M	-61.58M
Comprehensive Income	-386K	-250.93M
Shareholders Equity	207.62M	246.43M
Total Investments	117.19M	379K